These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1503 related items for PubMed ID: 9234575

  • 1. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
    Martino R, Lopez R, Sureda A, Brunet S, Domingo-Albós A.
    Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
    [Abstract] [Full Text] [Related]

  • 2. [Prevention of fungal infections in children and adolescents with cancer].
    Groll AH, Ritter J, Müller FM.
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364
    [Abstract] [Full Text] [Related]

  • 3. Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases.
    Martino R, Nomdedéu J, Altés A, Sureda A, Brunet S, Martínez C, Domingo-Albós A.
    Bone Marrow Transplant; 1994 Mar; 13(3):265-9. PubMed ID: 8199569
    [Abstract] [Full Text] [Related]

  • 4. Invasive pulmonary aspergillosis in patients with hematologic malignancies: survival and prognostic factors.
    Subirà M, Martino R, Franquet T, Puzo C, Altés A, Sureda A, Brunet S, Sierra J.
    Haematologica; 2002 May; 87(5):528-34. PubMed ID: 12010668
    [Abstract] [Full Text] [Related]

  • 5. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
    Glasmacher A, Cornely O, Ullmann AJ, Wedding U, Bodenstein H, Wandt H, Boewer C, Pasold R, Wolf HH, Hänel M, Dölken G, Junghanss C, Andreesen R, Bertz H, Itraconazole Research Group of Germany.
    J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
    [Abstract] [Full Text] [Related]

  • 6. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
    Glasmacher A, Prentice AG.
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
    [Abstract] [Full Text] [Related]

  • 7. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.
    Sinkó J, Csomor J, Nikolova R, Lueff S, Kriván G, Reményi P, Bátai A, Masszi T.
    Transpl Infect Dis; 2008 Apr; 10(2):106-9. PubMed ID: 17605727
    [Abstract] [Full Text] [Related]

  • 8. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
    Oren I, Rowe JM, Sprecher H, Tamir A, Benyamini N, Akria L, Gorelik A, Dally N, Zuckerman T, Haddad N, Fineman R, Dann EJ.
    Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
    [Abstract] [Full Text] [Related]

  • 9. Invasive pulmonary aspergillosis prior to BMT in acute leukemia patients does not predict a poor outcome.
    Richard C, Romón I, Baro J, Insunza A, Loyola I, Zurbano F, Tapia M, Iriondo A, Conde E, Zubizarreta A.
    Bone Marrow Transplant; 1993 Sep; 12(3):237-41. PubMed ID: 8241983
    [Abstract] [Full Text] [Related]

  • 10. Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies.
    Mehta J, Kelsey S, Chu P, Powles R, Hazel D, Riley U, Evans C, Newland A, Treleaven J, Singhal S.
    Bone Marrow Transplant; 1997 Jul; 20(1):39-43. PubMed ID: 9232254
    [Abstract] [Full Text] [Related]

  • 11. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Mattiuzzi GN, Estey E, Raad I, Giles F, Cortes J, Shen Y, Kontoyiannis D, Koller C, Munsell M, Beran M, Kantarjian H.
    Cancer; 2003 Jan 15; 97(2):450-6. PubMed ID: 12518369
    [Abstract] [Full Text] [Related]

  • 12. Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group.
    Kern W, Behre G, Rudolf T, Kerkhoff A, Grote-Metke A, Eimermacher H, Kubica U, Wörmann B, Büchner T, Hiddemann W.
    Cancer; 1998 Jul 15; 83(2):291-301. PubMed ID: 9669812
    [Abstract] [Full Text] [Related]

  • 13. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
    Safdar A, Rodriguez GH, Lichtiger B, Dickey BF, Kontoyiannis DP, Freireich EJ, Shpall EJ, Raad II, Kantarjian HM, Champlin RE.
    Cancer; 2006 Jun 15; 106(12):2664-71. PubMed ID: 16691620
    [Abstract] [Full Text] [Related]

  • 14. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
    Koh LP, Kurup A, Goh YT, Fook-Chong SM, Tan PH.
    Am J Hematol; 2002 Dec 15; 71(4):260-7. PubMed ID: 12447954
    [Abstract] [Full Text] [Related]

  • 15. A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients.
    Nucci M, Biasoli I, Akiti T, Silveira F, Solza C, Barreiros G, Spector N, Derossi A, Pulcheri W.
    Clin Infect Dis; 2000 Feb 15; 30(2):300-5. PubMed ID: 10671332
    [Abstract] [Full Text] [Related]

  • 16. [Clinical features and treatment of invasive fungal infection in 47 patients with hematological malignancies].
    Zhu Y, Chen SP, Shu YG, Xu YJ.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan 15; 33(1):89-92. PubMed ID: 18245913
    [Abstract] [Full Text] [Related]

  • 17. Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases.
    Reichenberger F, Habicht J, Kaim A, Dalquen P, Bernet F, Schläpfer R, Stulz P, Perruchoud AP, Tichelli A, Gratwohl A, Tamm M.
    Am J Respir Crit Care Med; 1998 Sep 15; 158(3):885-90. PubMed ID: 9731021
    [Abstract] [Full Text] [Related]

  • 18. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
    Trenschel R, Peceny R, Runde V, Elmaagacli A, Dermoumi H, Heintschel von Heinegg E, Müller KD, Schaefer UW, Beelen DW.
    Bone Marrow Transplant; 2000 Nov 15; 26(9):993-7. PubMed ID: 11100279
    [Abstract] [Full Text] [Related]

  • 19. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis.
    Kontoyiannis DP, Boktour M, Hanna H, Torres HA, Hachem R, Raad II.
    Cancer; 2005 Jun 01; 103(11):2334-7. PubMed ID: 15844093
    [Abstract] [Full Text] [Related]

  • 20. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A, van Rhee F, Henslee-Downey JP, Singhal S, Mehta J.
    Bone Marrow Transplant; 2001 Nov 01; 28(9):873-8. PubMed ID: 11781648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 76.